[1]
Virani SS,Alonso A,Benjamin EJ,Bittencourt MS,Callaway CW,Carson AP,Chamberlain AM,Chang AR,Cheng S,Delling FN,Djousse L,Elkind MSV,Ferguson JF,Fornage M,Khan SS,Kissela BM,Knutson KL,Kwan TW,Lackland DT,Lewis TT,Lichtman JH,Longenecker CT,Loop MS,Lutsey PL,Martin SS,Matsushita K,Moran AE,Mussolino ME,Perak AM,Rosamond WD,Roth GA,Sampson UKA,Satou GM,Schroeder EB,Shah SH,Shay CM,Spartano NL,Stokes A,Tirschwell DL,VanWagner LB,Tsao CW, Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3;
[PubMed PMID: 31992061]
[2]
Adams HP Jr,Bendixen BH,Kappelle LJ,Biller J,Love BB,Gordon DL,Marsh EE 3rd, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;
[PubMed PMID: 7678184]
Level 1 (high-level) evidence
[3]
Amarenco P,Bogousslavsky J,Caplan LR,Donnan GA,Wolf ME,Hennerici MG, The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovascular diseases (Basel, Switzerland). 2013;
[PubMed PMID: 23899749]
[4]
Bechich S,Arboix A, [Significant regression of neurological hemispheric deficit]. Neurologia (Barcelona, Spain). 1997 Jan;
[PubMed PMID: 9131915]
[7]
MacDougall NJ,Amarasinghe S,Muir KW, Secondary prevention of stroke. Expert review of cardiovascular therapy. 2009 Sep;
[PubMed PMID: 19764863]
[9]
Reddy ST,Garg T,Shah C,Nascimento FA,Imran R,Kan P,Bowry R,Gonzales N,Barreto A,Kumar A,Volpi J,Misra V,Chiu D,Gadhia R,Savitz SI, Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. Case reports in neurology. 2020 May-Aug;
[PubMed PMID: 32647526]
Level 2 (mid-level) evidence
[10]
Hart RG,Diener HC,Coutts SB,Easton JD,Granger CB,O'Donnell MJ,Sacco RL,Connolly SJ, Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet. Neurology. 2014 Apr;
[PubMed PMID: 24646875]
Level 3 (low-level) evidence
[11]
Arboix A,Alió J, Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Current cardiology reviews. 2010 Aug;
[PubMed PMID: 21804774]
[12]
Timsit SG,Sacco RL,Mohr JP,Foulkes MA,Tatemichi TK,Wolf PA,Price TR,Hier DB, Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 1992 Apr;
[PubMed PMID: 1561677]
[14]
Mantero V,Filizzolo M,Botto E,Giussani G,Aliprandi A,Basilico P,Scaccabarozzi C,Salmaggi A, Size, shape and location of lacunar strokes and correlation with risk factors. Clinical neurology and neurosurgery. 2020 Mar;
[PubMed PMID: 31918381]
[15]
Yaghi S,Trivedi T,Henninger N,Giles J,Liu A,Nagy M,Kaushal A,Azher I,Mac Grory B,Fakhri H,Brown Espaillat K,Asad SD,Pasupuleti H,Martin H,Tan J,Veerasamy M,Liberman AL,Esenwa C,Cheng N,Moncrieffe K,Moeini-Naghani I,Siddu M,Scher E,Leon Guerrero CR,Khan M,Nouh A,Mistry E,Keyrouz S,Furie K, Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk. Annals of neurology. 2020 Jul 12;
[PubMed PMID: 32656768]
[16]
Paciaroni M,Agnelli G,Falocci N,Caso V,Becattini C,Marcheselli S,Rueckert C,Pezzini A,Poli L,Padovani A,Csiba L,Szabó L,Sohn SI,Tassinari T,Abdul-Rahim AH,Michel P,Cordier M,Vanacker P,Remillard S,Alberti A,Venti M,Scoditti U,Denti L,Orlandi G,Chiti A,Gialdini G,Bovi P,Carletti M,Rigatelli A,Putaala J,Tatlisumak T,Masotti L,Lorenzini G,Tassi R,Guideri F,Martini G,Tsivgoulis G,Vadikolias K,Liantinioti C,Corea F,Del Sette M,Ageno W,De Lodovici ML,Bono G,Baldi A,D'Anna S,Sacco S,Carolei A,Tiseo C,Acciarresi M,D'Amore C,Imberti D,Zabzuni D,Doronin B,Volodina V,Consoli D,Galati F,Pieroni A,Toni D,Monaco S,Baronello MM,Barlinn K,Pallesen LP,Kepplinger J,Bodechtel U,Gerber J,Deleu D,Melikyan G,Ibrahim F,Akhtar N,Mosconi MG,Bubba V,Silvestri I,Lees KR, Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. Stroke. 2015 Aug;
[PubMed PMID: 26130094]
[17]
Hariri E,Hachem A,Sarkis G,Nasr S, Optimal Duration of Monitoring for Atrial Fibrillation in Cryptogenic Stroke: A Nonsystematic Review. BioMed research international. 2016;
[PubMed PMID: 27314027]
Level 1 (high-level) evidence
[18]
Tissue plasminogen activator for acute ischemic stroke. The New England journal of medicine. 1995 Dec 14;
[PubMed PMID: 7477192]
[19]
Nogueira RG,Jadhav AP,Haussen DC,Bonafe A,Budzik RF,Bhuva P,Yavagal DR,Ribo M,Cognard C,Hanel RA,Sila CA,Hassan AE,Millan M,Levy EI,Mitchell P,Chen M,English JD,Shah QA,Silver FL,Pereira VM,Mehta BP,Baxter BW,Abraham MG,Cardona P,Veznedaroglu E,Hellinger FR,Feng L,Kirmani JF,Lopes DK,Jankowitz BT,Frankel MR,Costalat V,Vora NA,Yoo AJ,Malik AM,Furlan AJ,Rubiera M,Aghaebrahim A,Olivot JM,Tekle WG,Shields R,Graves T,Lewis RJ,Smith WS,Liebeskind DS,Saver JL,Jovin TG, Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. The New England journal of medicine. 2018 Jan 4;
[PubMed PMID: 29129157]
[20]
Berkhemer OA,Fransen PS,Beumer D,van den Berg LA,Lingsma HF,Yoo AJ,Schonewille WJ,Vos JA,Nederkoorn PJ,Wermer MJ,van Walderveen MA,Staals J,Hofmeijer J,van Oostayen JA,Lycklama à Nijeholt GJ,Boiten J,Brouwer PA,Emmer BJ,de Bruijn SF,van Dijk LC,Kappelle LJ,Lo RH,van Dijk EJ,de Vries J,de Kort PL,van Rooij WJ,van den Berg JS,van Hasselt BA,Aerden LA,Dallinga RJ,Visser MC,Bot JC,Vroomen PC,Eshghi O,Schreuder TH,Heijboer RJ,Keizer K,Tielbeek AV,den Hertog HM,Gerrits DG,van den Berg-Vos RM,Karas GB,Steyerberg EW,Flach HZ,Marquering HA,Sprengers ME,Jenniskens SF,Beenen LF,van den Berg R,Koudstaal PJ,van Zwam WH,Roos YB,van der Lugt A,van Oostenbrugge RJ,Majoie CB,Dippel DW, A randomized trial of intraarterial treatment for acute ischemic stroke. The New England journal of medicine. 2015 Jan 1;
[PubMed PMID: 25517348]
Level 1 (high-level) evidence
[21]
Goyal M,Demchuk AM,Menon BK,Eesa M,Rempel JL,Thornton J,Roy D,Jovin TG,Willinsky RA,Sapkota BL,Dowlatshahi D,Frei DF,Kamal NR,Montanera WJ,Poppe AY,Ryckborst KJ,Silver FL,Shuaib A,Tampieri D,Williams D,Bang OY,Baxter BW,Burns PA,Choe H,Heo JH,Holmstedt CA,Jankowitz B,Kelly M,Linares G,Mandzia JL,Shankar J,Sohn SI,Swartz RH,Barber PA,Coutts SB,Smith EE,Morrish WF,Weill A,Subramaniam S,Mitha AP,Wong JH,Lowerison MW,Sajobi TT,Hill MD, Randomized assessment of rapid endovascular treatment of ischemic stroke. The New England journal of medicine. 2015 Mar 12;
[PubMed PMID: 25671798]
Level 1 (high-level) evidence
[22]
Jovin TG,Chamorro A,Cobo E,de Miquel MA,Molina CA,Rovira A,San Román L,Serena J,Abilleira S,Ribó M,Millán M,Urra X,Cardona P,López-Cancio E,Tomasello A,Castaño C,Blasco J,Aja L,Dorado L,Quesada H,Rubiera M,Hernandez-Pérez M,Goyal M,Demchuk AM,von Kummer R,Gallofré M,Dávalos A, Thrombectomy within 8 hours after symptom onset in ischemic stroke. The New England journal of medicine. 2015 Jun 11;
[PubMed PMID: 25882510]
[23]
Saver JL,Goyal M,Bonafe A,Diener HC,Levy EI,Pereira VM,Albers GW,Cognard C,Cohen DJ,Hacke W,Jansen O,Jovin TG,Mattle HP,Nogueira RG,Siddiqui AH,Yavagal DR,Baxter BW,Devlin TG,Lopes DK,Reddy VK,du Mesnil de Rochemont R,Singer OC,Jahan R, Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. The New England journal of medicine. 2015 Jun 11;
[PubMed PMID: 25882376]
[24]
Campbell BC,Mitchell PJ,Kleinig TJ,Dewey HM,Churilov L,Yassi N,Yan B,Dowling RJ,Parsons MW,Oxley TJ,Wu TY,Brooks M,Simpson MA,Miteff F,Levi CR,Krause M,Harrington TJ,Faulder KC,Steinfort BS,Priglinger M,Ang T,Scroop R,Barber PA,McGuinness B,Wijeratne T,Phan TG,Chong W,Chandra RV,Bladin CF,Badve M,Rice H,de Villiers L,Ma H,Desmond PM,Donnan GA,Davis SM, Endovascular therapy for ischemic stroke with perfusion-imaging selection. The New England journal of medicine. 2015 Mar 12;
[PubMed PMID: 25671797]
[25]
Albers GW,Marks MP,Kemp S,Christensen S,Tsai JP,Ortega-Gutierrez S,McTaggart RA,Torbey MT,Kim-Tenser M,Leslie-Mazwi T,Sarraj A,Kasner SE,Ansari SA,Yeatts SD,Hamilton S,Mlynash M,Heit JJ,Zaharchuk G,Kim S,Carrozzella J,Palesch YY,Demchuk AM,Bammer R,Lavori PW,Broderick JP,Lansberg MG, Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. The New England journal of medicine. 2018 Feb 22;
[PubMed PMID: 29364767]
[26]
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet (London, England). 1994 Mar 19;
[PubMed PMID: 7907677]
[27]
Segal JB,McNamara RL,Miller MR,Kim N,Goodman SN,Powe NR,Robinson KA,Bass EB, Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. Journal of general internal medicine. 2000 Jan;
[PubMed PMID: 10632835]
Level 1 (high-level) evidence
[28]
Saver JL,Carroll JD,Thaler DE,Smalling RW,MacDonald LA,Marks DS,Tirschwell DL, Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. The New England journal of medicine. 2017 Sep 14;
[PubMed PMID: 28902590]
[29]
Mas JL,Derumeaux G,Guillon B,Massardier E,Hosseini H,Mechtouff L,Arquizan C,Béjot Y,Vuillier F,Detante O,Guidoux C,Canaple S,Vaduva C,Dequatre-Ponchelle N,Sibon I,Garnier P,Ferrier A,Timsit S,Robinet-Borgomano E,Sablot D,Lacour JC,Zuber M,Favrole P,Pinel JF,Apoil M,Reiner P,Lefebvre C,Guérin P,Piot C,Rossi R,Dubois-Randé JL,Eicher JC,Meneveau N,Lusson JR,Bertrand B,Schleich JM,Godart F,Thambo JB,Leborgne L,Michel P,Pierard L,Turc G,Barthelet M,Charles-Nelson A,Weimar C,Moulin T,Juliard JM,Chatellier G, Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. The New England journal of medicine. 2017 Sep 14;
[PubMed PMID: 28902593]
[30]
Søndergaard L,Kasner SE,Rhodes JF,Andersen G,Iversen HK,Nielsen-Kudsk JE,Settergren M,Sjöstrand C,Roine RO,Hildick-Smith D,Spence JD,Thomassen L, Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. The New England journal of medicine. 2017 Sep 14;
[PubMed PMID: 28902580]
[31]
Diener HC,Sacco RL,Easton JD,Granger CB,Bernstein RA,Uchiyama S,Kreuzer J,Cronin L,Cotton D,Grauer C,Brueckmann M,Chernyatina M,Donnan G,Ferro JM,Grond M,Kallmünzer B,Krupinski J,Lee BC,Lemmens R,Masjuan J,Odinak M,Saver JL,Schellinger PD,Toni D,Toyoda K, Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. The New England journal of medicine. 2019 May 16;
[PubMed PMID: 31091372]
[32]
Hart RG,Sharma M,Mundl H,Kasner SE,Bangdiwala SI,Berkowitz SD,Swaminathan B,Lavados P,Wang Y,Wang Y,Davalos A,Shamalov N,Mikulik R,Cunha L,Lindgren A,Arauz A,Lang W,Czlonkowska A,Eckstein J,Gagliardi RJ,Amarenco P,Ameriso SF,Tatlisumak T,Veltkamp R,Hankey GJ,Toni D,Bereczki D,Uchiyama S,Ntaios G,Yoon BW,Brouns R,Endres M,Muir KW,Bornstein N,Ozturk S,O'Donnell MJ,De Vries Basson MM,Pare G,Pater C,Kirsch B,Sheridan P,Peters G,Weitz JI,Peacock WF,Shoamanesh A,Benavente OR,Joyner C,Themeles E,Connolly SJ, Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. The New England journal of medicine. 2018 Jun 7;
[PubMed PMID: 29766772]
[33]
Kamel H,Longstreth WT Jr,Tirschwell DL,Kronmal RA,Broderick JP,Palesch YY,Meinzer C,Dillon C,Ewing I,Spilker JA,Di Tullio MR,Hod EA,Soliman EZ,Chaturvedi S,Moy CS,Janis S,Elkind MS, The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. International journal of stroke : official journal of the International Stroke Society. 2019 Feb;
[PubMed PMID: 30196789]
Level 1 (high-level) evidence
[34]
Akhtar N,Bhutta Z,Kamran S,Babu B,Jose N,Joseph S,Morgan D,Francis R,Own A,Shuaib A, Stroke Mimics: A five-year follow-up study from the Qatar Stroke Database. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2020 Oct;
[PubMed PMID: 32912536]
[35]
Fritz SL,Light KE,Patterson TS,Behrman AL,Davis SB, Active finger extension predicts outcomes after constraint-induced movement therapy for individuals with hemiparesis after stroke. Stroke. 2005 Jun
[PubMed PMID: 15890987]
[36]
Smania N,Paolucci S,Tinazzi M,Borghero A,Manganotti P,Fiaschi A,Moretto G,Bovi P,Gambarin M, Active finger extension: a simple movement predicting recovery of arm function in patients with acute stroke. Stroke. 2007 Mar
[PubMed PMID: 17255546]
[37]
Feng W,Wang J,Chhatbar PY,Doughty C,Landsittel D,Lioutas VA,Kautz SA,Schlaug G, Corticospinal tract lesion load: An imaging biomarker for stroke motor outcomes. Annals of neurology. 2015 Dec
[PubMed PMID: 26289123]
[38]
Feigin VL,Forouzanfar MH,Krishnamurthi R,Mensah GA,Connor M,Bennett DA,Moran AE,Sacco RL,Anderson L,Truelsen T,O'Donnell M,Venketasubramanian N,Barker-Collo S,Lawes CM,Wang W,Shinohara Y,Witt E,Ezzati M,Naghavi M,Murray C, Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2014 Jan 18
[PubMed PMID: 24449944]
[39]
Role of noradrenergic system in cerebral arterial spasm after subarachnoid hemorrhage., Gotoh F,Muramatsu F,Kanda T,Fukuuchi Y,Yamamoto M,Iwagaki T,Amano T,Okayasu H,Tanaka K,, Acta neurologica Scandinavica. Supplementum, 1977
[PubMed PMID: 12403956]
[40]
CBF and metabolism in hepatic encephalopathy: effects of acute hyperammoneamia and of L. dopa., Baldy-Moulinier M,Bories P,, Acta neurologica Scandinavica. Supplementum, 1977
[PubMed PMID: 10582989]
[41]
Biochemical and behavioral disturbances induced by hypoxic hypoxia in rats., Boismare F,Le Poncin M,Lefrancois J,Marchand JC,, Acta neurologica Scandinavica. Supplementum, 1977
[PubMed PMID: 21216670]
[42]
The effect of hypobaric hypoxia on cerebral uptake of 3H deoxyglucose and norepinephrine turn over rate in rats., Rapin JR,Servin A,Bralet J,, Acta neurologica Scandinavica. Supplementum, 1977
[PubMed PMID: 31662037]